Medication safety shorts

CPD credit

1 CPD credit is available until 2 October 2024 after watching this series.

Complete the medication safety shorts form to access your CPD credit.

SGLT2 inhibitors

Dr Frankel discusses the clinical benefits of SGLT2 inhibitors, the potential risk of euglycaemic diabetic ketoacidosis and how to manage their prescribing in both chronic kidney disease and acute kidney injury.

Dr Andrew Frankel

Consultant nephrologist, Imperial College Healthcare NHS trust

Parkinson's time critical medication

Dr Acheson on time-critical scheduled medications, which must be administered within 30 minutes before or after their scheduled dosing time, for a total window of 1 hour. For anyone with Parkinson's, the impact of not getting medication on time in hospital can be severe. 

Dr Jonny Acheson

Emergency medicine consultant and director of engagement at the Parkinson's Excellence Network

Vasopressin deficiency: the importance of desmopressin

Desmopressin is a drug that acts on the vasopressin receptors of the body. It has many relevant clinical uses, ranging from nocturnal enuresis to hemophilia. Professor Miles Levy explains the importance of prescribing desmopressin as a critical medication, getting early input from an endocrinology specialist and close assessment of fluid balance.

Professor Miles Levy

Consultant endocrinologist and honorary associate professor at Leicester University

The impact of steroids on diabetes control

Professor Ketan Dhatariya on the prevalence of steroid use in the community and the impact of steroids on diabetes control.

Professor Ketan Dhatariya

Consultant in diabetes and endocrinology and general medicine

Published

22 August 2023

Theme

Patient Safety

Sub Theme

Using medicines safely

About

Financial support for this series was provided as an Independent Medical Education Grant from Pfizer Limited.

Further resources

Video

Webinar series: Medication safety

A series of expert discussions on medication safety topics including safety during transitions of care and problematic polypharmacy.

Reading

Polypharmacy: Managing medicine

This NHS Scotland Managing Multiple Medicines app and website provide information and tools to support healthcare professionals, patients and carers. 

Reading

GP Evidence

GP Evidence summaries of the evidence on the benefits and harms of treatments for long term conditions. 

Reading

WHO: Medication safety for look-alike, sound-alike medicines

This publication is one of the documents in the WHO Technical Series on Medication Safety Solutions.